if additional approvals are required, the final response time may take up to 6 months
Vyvanse (lisdexamfetamine dimesylate) is a prescription medication approved by the FDA for the treatment of moderate to severe Binge Eating Disorder in adults
Moreover, Novo Nordisk is adopting various growth strategies such as launching Wegovy in various Asian Countries which is expected to augment the Asia Wegovy market over the analysis period
Understanding why hunger can persist and how to manage it effectively can make the difference between frustration and long-term success
The medication does not cause physical dependence, so there are no withdrawal symptoms in the traditional sense, though metabolic changes will occur as the drug's effects diminish
For Rybelsus (oral semaglutide), taking the medication exactly as directedwith no more than 4 ounces of plain water, at least 30 minutes before the first food, beverage, or other oral medications of the day, and remaining upright for at least 30 minutesmay help minimize GI effects